Korean J Physiol Pharmacol.
1997 Dec;1(6):825-830.
The effect of rebamipide on cellular release of leukotriene B4 by
Helicobacter pylori
- Affiliations
-
- 1Department of Biology, Sangmyung University, Seoul 110-799 South Korea.
- 2Department of Degenerative Disease, National Institute of Health, Seoul 110-799 South Korea.
- 3Department of Pharmacology, College of Medicine, Yonsei University, South Korea.
- 4Department of Microbiology, College of Medicine, Gyeongsan National University, South Korea.
- 5Department of Pharmacology, College of Medicine, Seoul National University, Seoul 110-799, South Korea.
Abstract
-
Leukotrienes (LTs) are known to act as a mediator provoking tissue
response in inflammation. This finding implicates that LTs also play
important roles in the pathogenesis of H. pylori-induced gastritis and
gastric ulceration. Rebamipide is being currently used as a
therapeutics for gastritis and peptic ulcer, but their mechanisms of
action have not been known clearly yet. One possibility is that their
therapeutic effects are ascribed to interfering with the H.
pylori-induced release of LTs from neutrophils and gastric mucosal
cells. In the present study, this possibility was tested using LTB4 as
the test material in human neutrophils and Kato III cells(gastric
adenoma cells as a substitute for gastric mucosal cells). The release
of LTB4 from both neutrophils and Kato III cells was time and H.
pylori-dose dependent. The maximum release of LTB4 was induced by
neutrophils and Kato III cells when these cells incubated with H.
pylori 4.8 X 108 cells/ml for 30 min. But in the presence of rebamipide
the release of LTB4 from these cells was suppressed in dose dependent
manners. The release was completely suppressed at 1.0 mM of rebamipide
in neutrophils and 2.0 mM of this drug in Kato III cells, respectively.
We also obtained the results that the release of LTB4 was induced by
A23187 (Ca2+ ionophore) and the A23187-induced release was also
inhibited by rebamipide. It seems that the mechanism of action of
rebamipide is through its interaction with the level of intracellular
Ca2+. In view of the roles of LTB4 in inflammatory reaction and the
roles of H. pylori in gastritis and peptic ulcer, the effects of this
drug observed in this study may contribute to their therapeutic action
in these gastric disorders.